相关实验视频

Updated: Jul 25, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K

[MELK抑制剂OTSSP167对扩散型大B细胞淋巴瘤的影响]

Jun-Yi Zhou1, Hao Huang1, Yan Zhuang1

  • 1The Huaian Clinical College of Xuzhou Medical University, Huai'an 223300, Jiangsu Province, China.

Zhongguo shi yan xue ye xue za zhi
|June 25, 2023
PubMed
概括

MELK抑制剂OTSSP167有效地降低了扩散性大B细胞淋巴瘤 (DLBCL) 细胞活性和增殖,同时促进了细胞亡. 这种化合物在抑制DLBCL生长方面表现有前途,无论是体外还是体外.

关键词:
它们的扩散和扩散.这是一种MELK抑制剂.在OTSSP1677中使用OTSSP.灭症 (apoptosis) 是一种死亡的过程.扩散大的B细胞淋巴瘤.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

3.0K

相关概念视频